Great week at the ADA Diabetes conference in Orlando with 4 poster presentations and lots of good interactions and meetings.
Zucara Therapeutics Inc.
Biotechnology Research
Vancouver, BC British Columbia 903 followers
Zucara is developing the first once-daily therapeutic to prevent hypoglycemia (low blood sugar) in people with diabetes.
About us
Zucara Therapeutics, a CDRD and MaRS Innovation portfolio company, is developing the first drug therapy to prevent hypoglycemia in people with diabetes. Our first-in-class therapeutic is focused on improving glucagon counterregulation by inhibiting somatostatin which is dysregulated in Type 1 diabetes. Preventing hypoglycemia will dramatically change diabetes disease management, improving both patient health and quality of life..
- Website
-
http://www.zucara.ca
External link for Zucara Therapeutics Inc.
- Industry
- Biotechnology Research
- Company size
- 2-10 employees
- Headquarters
- Vancouver, BC British Columbia
- Type
- Privately Held
- Founded
- 2015
- Specialties
- diabetes, hypoglycemia, drug therapy, and insulin
Locations
-
Primary
Get directions
4th Floor 2405 Wesbrook Mall
Vancouver, BC British Columbia V6T 1Z3, CA
-
Get directions
661 University Avenue
1300
Toronto, Ontario M5G 0B7, CA
Employees at Zucara Therapeutics Inc.
-
Chris Garabedian
CEO, Xontogeny and Portfolio Manager, PXV Fund
-
Susan Peers
Directory, Clinical & Regulatory Affairs at Zucara Therapeutics Inc.
-
Michael Midmer
Chief Executive Officer at Zucara Therapeutics Inc.
-
Fred Callori
Managing Director, Venture - Perceptive Advisors; Senior Partner - Xontogeny
Updates
-
I am excited to present at the 2024 Bloom Burton & Co. Healthcare Investor Conference this week. I will provide an update on Zucara’s progress with ZT-01 and our current Phase 2 “ZONE” clinical study to prevent nighttime hypoglycemia. #BBHIC2024
-
-
Here is a nice article about Zucara’s Phase 2 “ZONE” clinical study. Find out more about this trial and how ZT-01 is being developed to prevent nighttime hypoglycemia. https://lnkd.in/dSTxZkBk
-
Celebrating these amazing and bright women on the Zucara team! Happy International Women's Day. #internationalwomensday
-
-
Zucara presented its positive proof-of-concept Phase 1b results in two presentations at the #EASD2023 Diabetes conference this week receiving high interest.
-
-
Big milestone for Zucara as we dosed our first patient in the Phase 2a ZONE study! The ZONE study will evaluate the effect of ZT-01 on preventing nighttime hypoglycemia (low blood glucose) in people with Type 1 diabetes. https://lnkd.in/gN48gNr5
-
-
This podcast gives a really good sense of what it’s like living with diabetes and the issues of hypoglycemia. We are proud to be working on a solution, with ZT-01 soon to enter a Phase 2 trial. Hope you have a chance to listen. https://lnkd.in/gFiXGMJJ
-